Myasthenia gravis during pregnancy

References

• Giraud M, Beaurain G, Eymard B, Tranchant C, Gajdos P, Garchon HJ. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun.5(5), 398–404 (2004).
   PubMed Web of Science ®Google Scholar
• Ferrero S, Pretta S, Nicoletti A, Petrera P, Ragni N. Myasthenia gravis: management issues during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.121(2), 129–138 (2005).
   PubMed Web of Science ®Google Scholar
• Marrie RA, Sahlas DJ, Bray GM. Familial autoimmune myastenia gravis: four patients involving three generations. Can. J. Neurol. Sci.27(4), 307–310 (2000).
   PubMedGoogle Scholar
• Christensen PB, Jensen TS, Tsiropoulos I et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol. Scand.91(3), 192–195 (1995).
   PubMed Web of Science ®Google Scholar
• Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med.7(3), 365–368 (2001).
   PubMed Web of Science ®Google Scholar
• Stickler DE, Massey JM, Sanders DB. MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin. Neurophysiol.116(9), 2065–2068 (2005).
   PubMedGoogle Scholar
• Bartoccioni E, Scuderi F, Minicuci GM, Marino M, Ciaraffa F, Evoli A. Anti-MuSK antibodies: correlation with myasthenia gravis severity. Neurology67(3), 505–507 (2006).
   PubMed Web of Science ®Google Scholar
• Cikes N, Momoi MY, Williams CL et al. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin. Proc.62(8), 474–481 (1988).
   Google Scholar
• Jaretzki A III, Barohn RJ, Ernstoff RM et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology55(1), 16–23 (2000).
   PubMed Web of Science ®Google Scholar
• Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt. Sinai J. Med.38(6), 497–537 (1971).
   PubMed Web of Science ®Google Scholar
• Schlezinger NS. Pregnancy in myasthenia gravis and neonatal myasthenia gravis. Am. J. Med.19(5), 718–720 (1955).
   PubMedGoogle Scholar
• Mitchell PJ, Bebbington M. Myasthenia gravis in pregnancy. Obstet. Gynecol.80(2), 178–181 (1992).
   PubMed Web of Science ®Google Scholar
• Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology52(3), 447–452 (1999).
   PubMed Web of Science ®Google Scholar
• Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur. J. Obstet. Gynecol. Reprod. Biol.104(1), 21–25 (2002).
   PubMed Web of Science ®Google Scholar
• Picone O, Audibert F, Gajdos P, Fernandez H. [Myasthenia gravis and pregnancy. Report on 13 cases]. J. Gynecol. Obstet. Biol. Reprod. (Paris)32(7), 654–659 (2003).
   PubMedGoogle Scholar
• Tellez-Zenteno JF, Hernandez-Ronquillo L, Salinas V, Estanol B, da Silva O. Myasthenia gravis and pregnancy: clinical implications and neonatal outcome. BMC Musculoskelet. Disord.5, 42 (2004).
   PubMedGoogle Scholar
• Brenner T, Beyth Y, Abramsky O. Inhibitory effect of a-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor. Proc. Natl. Acad. Sci. USA77(6), 3635–3639 (1980).
   PubMedGoogle Scholar
• Plauche WC. Myasthenia gravis in mothers and their newborns. Clin. Obstet. Gynecol.34(1), 82–99 (1991).
   PubMed Web of Science ®Google Scholar
• Benshushan A, Rojansky N, Weinstein D. Myasthenia gravis and preeclampsia. Isr. J. Med. Sci.30(3), 229–233 (1994).
   PubMedGoogle Scholar
• Duff GB. Preeclampsia and the patient with myasthenia gravis. Obstet. Gynecol.54(3), 355–358 (1979).
   PubMedGoogle Scholar
• Cohen BA, London RS, Goldstein PJ. Myasthenia gravis and preeclampsia. Obstet. Gynecol.48(1 Suppl.), 35S–37S (1976).
   PubMedGoogle Scholar
• Bashuk RG, Krendel DA. Myasthenia gravis presenting as weakness after magnesium administration. Muscle Nerve13(8), 708–712 (1990).
   PubMedGoogle Scholar
• Di Spiezio Sardo A, Taylor A, Pellicano M et al. Myasthenia and HELLP syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol.116(1), 108–111 (2004).
   PubMedGoogle Scholar
• Giwa-Osagie OF, Newton JR, Larcher V. Obstetric performance of patients with my asthenia gravis. Int. J. Gynaecol. Obstet.19(4), 267–270 (1981).
   PubMedGoogle Scholar
• Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology61(10), 1362–1366 (2003).
   PubMed Web of Science ®Google Scholar
• Verspyck E, Mandelbrot L, Dommergues M et al. Myasthenia gravis with polyhydramnios in the fetus of an asymptomatic mother. Prenat. Diagn.13(6), 539–542 (1993).
   PubMedGoogle Scholar
• Roth T, Ackermann R, Stein R, Inderbitzi R, Rosler K, Schmid RA. Thirteen years follow-up after radical transsternal thymectomy for myasthenia gravis. Do short-term results predict long-term outcome? Eur. J. Cardiothorac. Surg.21(4), 664–670 (2002).
   PubMedGoogle Scholar
• Roth TC, Raths J, Carboni G, Rosler K, Schmid RA. Effect of pregnancy and birth on the course of myasthenia gravis before or after transsternal radical thymectomy. Eur. J. Cardiothorac. Surg.29(2), 231–235 (2006).
   PubMedGoogle Scholar
• Tellez Zenteno JF. Can we consider thymectomy before pregnancy in female patients with myasthenia gravis? Eur. J. Cardiothorac. Surg.30(2), 411–412; author reply 412 (2006).
   Google Scholar
• Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur. J. Neurol.14(1), 38–43 (2007).
   PubMed Web of Science ®Google Scholar
• Bartoccioni E, Evoli A, Casali C, Scoppetta C, Tonali P, Provenzano C. Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants. J. Neuroimmunol.12(2), 155–161 (1986).
   PubMedGoogle Scholar
• Melber D. Maternal-fetal transmission of myasthenia gravis with acetylcholine-receptor antibody. N. Engl. J. Med.318(15), 996 (1988).
   PubMedGoogle Scholar
• Hoff JM, Daltveit AK, Gilhus NE. Asymptomatic myasthenia gravis influences pregnancy and birth. Eur. J. Neurol.11(8), 559–562 (2004).
   PubMedGoogle Scholar
• Vernet-der Garabedian B, Lacokova M, Eymard B et al. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J. Clin. Invest.94(2), 555–559 (1994).
   PubMedGoogle Scholar
• Daskalakis GJ, Papageorgiou IS, Petrogiannis ND, Antsaklis AJ, Michalas SK. Myasthenia gravis and pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.89(2), 201–204 (2000).
   PubMedGoogle Scholar
• Carr SR, Gilchrist JM, Abuelo DN, Clark D. Treatment of antenatal myasthenia gravis. Obstet. Gynecol.78(3 Pt 2), 485–489 (1991).
   PubMedGoogle Scholar
• Behin A, Mayer M, Chatenoud L, Ferrer X, Espil-Taris C, Laforêt P, Eymard B. Severe neonatal myasthenia due to maternal anti-MuSK antibodies. Neuromuscul. Disord.16(9–10), 661–662 (2006).
   Google Scholar
• Boneva N, Frenkian-Cuvelier M, Bidault J, Brenner T, Berrih-Aknin S. Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J. Neuroimmunol.177(1–2), 119–131 (2006)
   PubMedGoogle Scholar
• Ciafaloni E, Massey JM. Myastenia gravis and pregnancy. In: Neurologic Disorders in Pregnancy. Washington JM (Ed.) The Parthenon Publishing Group, London, UK (2004) 120–132.
   Google Scholar
• Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch. Gynecol. Obstet.270(2), 79–85 (2004).
   PubMedGoogle Scholar
• Ferrero S, Esposito F, Pretta S, Ragni N. Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding. Expert Rev. Neurother.6(12), 1823–1831 (2006).
   PubMedGoogle Scholar
• American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics93(1), 137–150 (1994).
   PubMedGoogle Scholar
• Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: is it safe? BJOG114(4), 498–501 (2007).
   PubMed Web of Science ®Google Scholar
• Mottet C, Juillerat P, Pittet V et al. Pregnancy and breastfeeding in patients with Crohn’s disease. Digestion76(2), 149–160 (2007).
   PubMed Web of Science ®Google Scholar
• Nyberg G, Haljamae U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation65(2), 253–255 (1998).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics108(3), 776–789 (2001).
   PubMed Web of Science ®Google Scholar
• Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J. Clin. Invest.116(11), 2843–2854 (2006).
   PubMed Web of Science ®Google Scholar